As a member of the aldo-keto reductase family 1, AKR1C3 has been shown to be increased in erastin-resistant DU-145 prostate cancer cells in a recent study, suggesting that AKR1C3 might be a suppressor of cell ferroptosis [26]. The gene discussed is AKR1C3; the disease is prostate carcinoma.